Recombinant Llama VHH-Human IgG Antibody for studying neutralization of SARS-CoV-2 and detection of Spike glycoprotein. Neutralizing activity validated for wild type Spike protein RBD and Spike protein RBD (N501Y) variant.
Clonality:
Monoclonal
Concentration:
1
Clone Designation:
[HL14]
Buffer:
1 X PBS (pH7.4), 3% sucrose
Form:
Liquid
Target:
SARS-CoV-2 Spike protein
* VAT and and shipping costs not included. Errors and price changes excepted